Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes

S.G. Swinnen, F.J. Snoek, M.P. Dain, J.H. de Vries, J. Hoekstra-Slikkerveer, F. Holleman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)739-743
JournalDiabetes Technology and Therapeutics
Issue number11
Publication statusPublished - 2009

Cite this